Pricing Log in Create free account
Saturday 17 October 2026 Export A’s income statement to Excel — free account

Agilent Technologies, Inc.

A Healthcare Diagnostics & Research

Agilent Technologies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $6.9 billion, up 6.73% from fiscal 2024. In the quarter to July 2026, revenue grew 8.06%, EPS grew 8.47%, free cash flow grew 69.5% and total debt rose 8.81%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.

172.96 2.59 −1.48%
Market cap
$49.5B
P/E
34.0×
Fwd P/E
26.3×
Dividend yield
0.59%
F-score
5/9
Altman Z
5.46
Beneish M
−2.46
Dividend safety
86/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Agilent Technologies, Inc. (A) EV/EBITDA

Alert me on EV/EBITDA

As of 16 October 2026, Agilent Technologies, Inc. (A) trades at a EV/EBITDA of 26.5×. Over the past ten years it has ranged from 13.1× (September 2015) to 35.6× (September 2021); the current reading is higher than 85% of that period. That is above the Diagnostics & Research industry median of 24.3× and above the Healthcare sector median of 9.2×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 24.2× 6.25%
FY2024 22.8× 17.26%
FY2023 19.5× (12.55%)
FY2022 22.2× (24.12%)
FY2021 29.3× 1.41%
FY2020 28.9× 40.88%
FY2019 20.5× 12.34%
FY2018 18.3× (11.48%)
FY2017 20.6× 28.58%
FY2016 16.0× 1.45%

Quarterly newest first

Period EV/EBITDA Change
Jul 2026 21.4× 15.99%
Apr 2026 18.5× (18.92%)
Jan 2026 22.8× (6.03%)
Oct 2025 24.2× 21.82%
43 more quarters

Against its own ten years

Low 13.1× High 35.6×
Ten-year median 20.9×
Current reading's percentile 85

EV/EBITDA against peers

Company EV/EBITDA
NTRA Natera, Inc. compare n/m
DGX Quest Diagnostics Incorporated compare 14.1×
LH Labcorp Holdings Inc. compare 14.5×
IQV IQVIA Holdings Inc. compare 17.1×
A Agilent Technologies, Inc. 26.5×
MTD Mettler-Toledo International, Inc. compare 26.6×
IDXX IDEXX Laboratories, Inc. compare 27.6×
ILMN Illumina, Inc. compare 35.0×
WAT Waters Corporation compare 50.1×
Diagnostics & Research industry median 24.3×
Healthcare sector median 9.2×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on A